Literature DB >> 3402354

Systemic arterial hypertension and coronary atherosclerosis. Observations in survivors of a first myocardial infarction.

G Sánchez Torres1, C Posadas Romero, C Tena Tamayo, I Hernández Santamaría.   

Abstract

To determine the importance of systemic arterial hypertension (SAH) in the pathogenesis of coronary atherosclerosis (CA), the coronary stenosis (CSI), coronary diffuse atheromatous (CDAI) and coronary tortuosity (CTI) indices were assessed by selective coronary angiography (SCA) in 132 survivors of a definite first myocardial infarction (MI). Patients were divided into 2 groups according to the absence (group A, n = 60) or presence (group B, n = 72) of SAH. Group B was further subdivided into 2 subgroups: group B1, consisting of 62 patients receiving no antihypertensive treatment before admission, and group B2, consisting of 20 patients treated continuously for at least 2 years with a diuretic or diuretic + beta-blocker. There were no differences in age, topography of MI, serum total cholesterol and triglyceride concentrations, prevalence of diabetes mellitus or smoking habits, CSI and CTI among the groups or subgroups of patients. Group B had a higher CTI (7.2 +/- 2.8) than Group A (2.7 +/- 2.3, p less than or equal to 0.001). None of the above indices were statistically different between subgroups B1 and B2. Surprisingly, the degree and extent of CA assessed by CSI and CDAI were similar in this population, regardless of the presence or absence of SAH and whether or not patients were treated with a diuretic. Although hypertension was related to tortuosity of the coronary arteries, which does not have a strong role in the development of CA, it is possible that the hypertensive process is relevant to the installation of atheromatous disease but not to its progression. Further studies are needed to clarify this point.

Entities:  

Mesh:

Year:  1988        PMID: 3402354     DOI: 10.2165/00003495-198800356-00016

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  20 in total

1.  Susceptibility to coronary heart disease.

Authors:  T R DAWBER; W B KANNEL
Journal:  Mod Concepts Cardiovasc Dis       Date:  1961-07

2.  Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve.

Authors:  B E Strauer
Journal:  Am J Cardiol       Date:  1979-10       Impact factor: 2.778

3.  Plasma apoproteins and the severity of coronary artery disease.

Authors:  S P Sedlis; K B Schechtman; P A Ludbrook; B E Sobel; G Schonfeld
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

4.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

5.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

6.  Association of risk factor variables and coronary artery disease documented with angiography.

Authors:  D R Holmes; L R Elveback; R L Frye; B A Kottke; R D Ellefson
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

7.  Lipoprotein predictors of the severity of coronary artery disease in men and women.

Authors:  M F Reardon; P J Nestel; I H Craig; R W Harper
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

8.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings.

Authors:  E N Arnett; J M Isner; D R Redwood; K M Kent; W P Baker; H Ackerstein; W C Roberts
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

9.  Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.

Authors:  A I Goldman; B W Steele; H W Schnaper; A E Fitz; E D Frohlich; H M Perry
Journal:  JAMA       Date:  1980-10-10       Impact factor: 56.272

10.  [Clinical and coronary angiographic characteristics of hypertensive angina].

Authors:  G Sánchez Torres; S Trevethan Craviotto; D Bialostozky; E Gutiérrez Fuster; S Olvera Cruz
Journal:  Arch Inst Cardiol Mex       Date:  1981 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.